Trinity Biomedical Sciences Institute Hosts Entrepreneur Day
Dec 05, 2013
Trinity Biomedical Sciences Institute (TBSI) hosted a half-day event aimed to educate and inspire would-be science entrepreneurs, at which distinguished speakers from a variety of high-profile industry and venture capital backgrounds discussed their own stories and provided advice at Trinity College Dublin.
Speakers from industry included Henning Steinhagen, Senior Vice President and Head of Global Drug Discovery at Grunenthal, and Martin Welschof, Chief Executive Officer of Opsona Therapeutics, which is one of Ireland’s most successful companies working in Immunology. Speaking as venture capitalists were Ena Prosser of the Irish venture capital fund Fountain Healthcare, and Jan Adams of EMBL Ventures, Heidelberg.
Seamus Mulligan, one of Ireland’s most successful entrepreneurs in therapeutics, also spoke, before Barry McMahon, Director of Trinity’s Innovation Academy, and Niamh McGuinness, an Innovation Academy Ambassador, held a panel discussion.
Professor of Biochemistry and Director of TBSI, Luke O'Neill, said: “This was a really exciting event, which involved top-notch people from pharmaceutical and biotech companies, and from venture capital. We hope everyone who attended learned about career options in these areas, and maybe some were even inspired to set up their own businesses.”
Dec 20, 2013
Dec 09, 2013